Funding for the new model for facilitating basic and translational genomic science in the country will be matched by public and private donors to create 10 research "nodes."
The company recently published a clinical study showing the test could distinguish between bacterial and viral infections with an area under the curve of .94.
The study found that using Veristrat to guide patient therapy decreased the total lifetime direct medical cost per patient by $135.
The company has launched an early-access program for researchers interested in using the system for fractionation of proteomic samples.
OVA2 replaces two of the five OVA1 protein markers with new biomarkers and offers improved specificity and positive predictive value, the company said.
In PNAS this week: rare variants linked to bleeding disorder, comparison of whole-exome and whole-genome sequencing, and more.
George Church tells The Sunday Times that his group has inserted some woolly mammoth genes into elephant cells.
A Scientific Reports editor resigns over a new policy at the journal allowing researchers to pay to fast track the peer review of their manuscripts, and poll.
The National Cancer Institute's Harold Varmus discusses the state of cancer research with the New York Times.